Biomedical technologies keep Oklahoma’s economic engine healthy.
“As long as you have your health” is a cliché most of us relate to; as long as a person feels well, achievements are possible. So as an individual has the choice to protect and enhance her own health, Oklahoma itself has a focus on biotechnology, which has a flourishing role in the state’s economy. This, leaders say, is due to a powerful and symbiotic relationship between entrepreneurs, private and public investors, academic investigators and clinical researchers.
In 1996 Oklahoma City funded Presbyterian Health Foundation Research Park (PHF) – a campus of seven buildings totaling 700,000 square feet of space on a 27-acre site meant to provide biomedical firms with modest rent and Class-A facilities. The PHF states its mission as accelerating bioscience research discoveries to solutions that enhance human life. The much-improved PHF campus was one of many moves made then and continuing today by regional and state leaders to increase the state’s allure in the biomedical field.
Oklahoma City’s bioscience sector boasts annual revenues of more than $4.1 billion and employs more than 27,800 workers with total compensation of $1.5 billion.”
It appears to be working. CNN Money recently described Oklahoma City as a “haven for entrepreneurial risk-takers,” citing comparatively low costs of living and “a diverse local economy spread across medical research, energy, education and government. Oklahoma City also benefits from a high concentration of deep-pocketed local investors, many of them veterans of the oil and gas industry, who are willing to take a gamble on companies that might spend 10 years bringing a new product to fruition.”
It takes focused coordination to optimize the state’s biotechnology effort, and so, in 2008, the Oklahoma Bioscience Association was launched, says Eric Long, research economist for the Greater Oklahoma City Chamber. This established a strong, networked and collaborative bioscience community to promote industry growth and provide a strong voice.
Raising capital will continue to be an issue.
“The costs associated with the discovery of new knowledge and the development of new technologies is expensive,” says Long. “In addition to the research phase, large amounts of capital are needed for longer periods of time to fund business growth and economic development. There are costs involved in market analysis, pricing, developing prototypes, preparing marketing and sales plans and manufacturing. Once the product is developed, there are also costs for distribution, sales and marketing.”
The University of Oklahoma Health Sciences Center, comprised of seven medical schools, has benefited from PHF’s efforts, with more than $65 million in grants for medical research. In turn, the more-than-35 institutions on its campus employ more than 15,000 people with combined general revenue of more than $3.5 billion per year, according to Chamber reports.
“With a world-class caliber of research facilities and wet lab space, abundant funding opportunities and collaborative efforts by legislators to enhance progress, you could say greater Oklahoma City has biotechnology down to a science,” says Long. “Oklahoma City’s bioscience sector boasts annual revenues of more than $4.1 billion and employs more than 27,800 workers with total compensation of $1.5 billion.”
The Oklahoma Center for the Advancement of Science and Technology (OCAST), has funded 2,461 projects at more than $249 million, which has attracted $5.1 billion in private sector and federal dollars for a return on investment of 21:1.
Source: Oklahoma Bioscience Association